<p><b>Copyright information:</b></p><p>Taken from "Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer"</p><p>http://www.translational-medicine.com/content/6/1/2</p><p>Journal of Translational Medicine 2008;6():2-2.</p><p>Published online 8 Jan 2008</p><p>PMCID:PMC2235830.</p><p></p> Vessels were visualized with CD31 immunostaining. Four tumor microphotographs are combined for each treatment. 200× magnification. , Microvascular density quantification in ID8-Vegf tumors of control mice or mice treated with SU5416, paclitaxel or combination. * indicates p ≤ 0.05
<p>Immunohistochemical detection of endothelial CD31 (A, D, green) and VEGFR-2 (B, E, red) of microv...
Cancer is the second leading cause of death in the world after cardiovascular diseases. Some types o...
BackgroundVascular endothelial growth factors (VEGFs) are major regulators of intratumoral angiogene...
<p><b>Copyright information:</b></p><p>Taken from "Should tumor VEGF expression influence decisions ...
<p><b>Copyright information:</b></p><p>Taken from "Should tumor VEGF expression influence decisions ...
<p><b>Copyright information:</b></p><p>Taken from "Should tumor VEGF expression influence decisions ...
PURPOSE: Inhibition of angiogenesis has shown clinical success in patients with cancer. Thus, imagin...
<p>(<b>A</b>) Evolution of the tumor volume in mice pretreated with i.v. injections every 2 days of ...
<p>(A) The data represent mean tumor volumes ± SEM in 16K-Ad-treated (n = 8) or Null-Ad-treated (n =...
<p>LLC tumor-bearing C57BL6/J mice were systemically treated with control saline or with 2.5 mg/kg/d...
<p>(<b>A</b>) Representative pictures of CD34-stained Colo205 tumors (mean 800 mm<sup>3</sup>). (<b>...
<p>Angiogenesis phenotypes of microvessels evaluated by immunohistochemical staining of tumor xenogr...
Quantitative characterization of the in vivo effects of vascular-targeted therapies on tumor vessels...
<p>Xenograft tumors were engineered in immunodefficient mice by the co-transplantation of human tumo...
<p>(A) Representative photographs of HeLa tumors vascularized with either HDMEC or MDMEC. (B-D) Grap...
<p>Immunohistochemical detection of endothelial CD31 (A, D, green) and VEGFR-2 (B, E, red) of microv...
Cancer is the second leading cause of death in the world after cardiovascular diseases. Some types o...
BackgroundVascular endothelial growth factors (VEGFs) are major regulators of intratumoral angiogene...
<p><b>Copyright information:</b></p><p>Taken from "Should tumor VEGF expression influence decisions ...
<p><b>Copyright information:</b></p><p>Taken from "Should tumor VEGF expression influence decisions ...
<p><b>Copyright information:</b></p><p>Taken from "Should tumor VEGF expression influence decisions ...
PURPOSE: Inhibition of angiogenesis has shown clinical success in patients with cancer. Thus, imagin...
<p>(<b>A</b>) Evolution of the tumor volume in mice pretreated with i.v. injections every 2 days of ...
<p>(A) The data represent mean tumor volumes ± SEM in 16K-Ad-treated (n = 8) or Null-Ad-treated (n =...
<p>LLC tumor-bearing C57BL6/J mice were systemically treated with control saline or with 2.5 mg/kg/d...
<p>(<b>A</b>) Representative pictures of CD34-stained Colo205 tumors (mean 800 mm<sup>3</sup>). (<b>...
<p>Angiogenesis phenotypes of microvessels evaluated by immunohistochemical staining of tumor xenogr...
Quantitative characterization of the in vivo effects of vascular-targeted therapies on tumor vessels...
<p>Xenograft tumors were engineered in immunodefficient mice by the co-transplantation of human tumo...
<p>(A) Representative photographs of HeLa tumors vascularized with either HDMEC or MDMEC. (B-D) Grap...
<p>Immunohistochemical detection of endothelial CD31 (A, D, green) and VEGFR-2 (B, E, red) of microv...
Cancer is the second leading cause of death in the world after cardiovascular diseases. Some types o...
BackgroundVascular endothelial growth factors (VEGFs) are major regulators of intratumoral angiogene...